Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Argenta Discovery

Argenta Discovery is a new United Kingdom-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series. Argenta comprises a mix of scientists skilled in computer-aided drug design, medicinal and combinatorial chemistry, and assay development and automated biochemical screening, forming one team for the in vitro optimisation of candidates.

Argenta Discovery is also actively working on its own projects for which patentable lead series will be available for sale or license. Argenta has a contract with Imperial College of Science, Technology and Medicine in London for First Right of Refusal for targets from several research groups.


Contact Details:
Rainham Road South
Dagenham
Essex
RM10 7XS
United Kingdom
Tel:+44-20-8919-3421
Fax:+44-20-8919-3859
Email:info@argentadiscovery.com
WWW:

www.argentadiscovery.com/




Loading...

Recent Publications by Argenta Discovery:

Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
BACKGROUND: The proven efficacy of several anti-cholinergics and...
21st August, 2009
Argenta Discovery Ltd, 8-9 Spire Green Centre, Flex Meadow, Essex CM19 Expert Opin Ther Pat. 2009 Jan;19(1):1-12.
DOI Direct Link
The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory...
6th August, 2009
Argenta Discovery Ltd, Harlow, Essex, United Kingdom. Curr Opin Pharmacol. 2009 Jun;9(3):231-42. Epub 2009 Apr 6.
DOI Direct Link
Towards improving compound selection in structure-based virtual screening.
Structure-based virtual screening is now an established technology for...
20th September, 2008
Argenta Discovery Ltd., 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex Drug Discov Today. 2008 Mar;13(5-6):219-26. Epub 2008 Feb 4.
DOI Direct Link
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
A virtual screening approach comprising a 3-D similarity search based on...
6th December, 2007
Argenta Discovery Ltd, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, Bioorg Med Chem Lett. 2007 Sep 1;17(17):4901-5. Epub 2007 Jun 13.
DOI Direct Link
Quinazoline and benzimidazole MCH-1R antagonists.
We have modified the previously reported 2-aminoquinoline 1 to provide two...
16th May, 2007
Argenta Discovery Limited, 8/9 Spire Green Centre, Flex Meadow, Harlow, Bioorg Med Chem Lett. 2007 Mar 1;17(5):1403-7. Epub 2006 Dec 2.
DOI Direct Link

View more Argenta Discovery research publications.

Press Releases on Argenta Discovery:

BioPortfolio Logo
MNLpharma Strengthens Team 1st February, 2005 Mnlpharma
MNLpharma Strengthens Team Maidenhead, UK (21 February 2005) – MNLpharma (MNL) announced today it has added two key personnel to its team: Dr. Mike Rance as Non-Executive Director
Argenta Discovery Ltd Announces New Agreement with GlaxoSmithKline 1st January, 2004 Argenta
Argenta Discovery Ltd Announces New Agreement with GlaxoSmithKline  Harlow (UK), 26 January 2004... Argenta Discovery Ltd today announced that it has entered into a new
Argenta Discovery announces results for the year ended 31 1st June, 2003 Argenta
Argenta Discovery announces results for the year ended 31 March 2003 Harlow (UK), 19 June 2003....Argenta Discovery Ltd today announced its audited results
Managing Risk and Growth through Strategic Alliances and Partnerships 1st April, 2002 Nsep
  Managing Risk and Growth through Strategic Alliances and Partnerships With access to private and public capital severely limited, the options available to grow a company
Argenta Discovery appoints New Chief Financial Officer 1st January, 1970 Argenta
  Argenta Discovery appoints New Chief Financial Officer Harlow (UK), 7 October 2002....Argenta Discovery Ltd today announced that Mr Colin Knox

BioNews Results for Argenta Discovery:

Argenta Discovery Publishes Positive Data From a Phase II Proof of Concept Trial with Co-Administration of Inh
Pharma Live:  Sep 15 2009 1:50PM Matching: argenta discovery

Argenta Discovery Clinical Trials:

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 360 times since April 2007, the link to the organisation's website has been followed 54 times

Recent Search Terms used to find this page: argenta discovery patent | argenta discovery | .

Search for more companies in Dagenham

Search for more companies in Essex



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Argenta Discovery

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.